Recap: Bill would gut Kansas Bioscience Authority

May 19, 2015  |  Bobby Burch

KS StateCap2

A bill in the Kansas legislature if passed would dissolve the Kansas Bioscience Authority, which has recently served as a venture capital organization investing in early-stage bioscience firms.

The measure — SB 305 — would shut down the organization and transfer its funds and obligations to the Kansas Department of Commence.

Proponents of the KBA say that the dissolution of the KBA aims to help fill a projected $406 million shortfall in the Kansas budget. The bill’s sole supporter, Steven Anderson, a lobbyist for the Kansas Policy Institute and formerly Gov. Sam Brownback’s budget director, said the KBA’s mission is better served by the private sector, according to the Wichita Eagle.

Founded in 2004, the KBA invests in animal and human health, agribusiness and life sciences. It’s invested in such companies as Flow Forward, Metactive, Aratana and Innara Health.

KBA chief executive Duane Cantrell said the current value of KBA assets held in startup investments is $32 million to $34 million, according to the Kansas City Star. Cantrell reportedly testified to the Legislature that his organization has nabbed back assets worth $19 million through portfolio companies’ initial public offerings or exits.

For more information on this story, check out these links:

Kansas City Star: Kansas City business leaders oppose bill that would kill the Kansas Bioscience Authority

Kansas City Business Journal: Kansas Bioscience Authority fans voice support at the Capitol

Topeka Capital Journal: Senate explores bill closing state’s bioscience agency

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged , , , ,
Featured Business
    Featured Founder

      2015 Startups to Watch

        stats here

        Related Posts on Startland News

        KC innovator’s anti-itch spray so natural it was discovered on a front porch lab

        By Tommy Felts | September 21, 2022

        Homindy founder Ronan Molloy discovered the benefits of his company’s itch relief spray somewhat by accident. During the summer of 2020, Molloy volunteered to participate in a clinical study for a tea with all-natural ingredients that was supposed to reduce inflammation in his right knee. At that time, he was president of the Innovation Stockyard,…

        KC capital implants cattle tech startup with fuel to scale, expanding IVF labs, headcount 

        By Tommy Felts | September 20, 2022

        Livestock production has seen a remarkable transformation since Kerryann Kocher was growing up on her family’s sixth-generation farm in northeast Iowa, the Vytelle CEO said. Instead of just selecting the cow that looks best and bringing in the neighbor’s bull for breeding, as she remembers it, Kocher and Vytelle — a Kansas City-based precision livestock…

        Venture experts: Getting your first check in KC is too difficult, but a record influx of coastal investors isn’t a bad substitute

        By Tommy Felts | September 20, 2022

        A new report on Kansas City’s venture-backed companies showed year-over-year growth in multiple areas — impressing industry experts who identified key investment trends in the data. More companies with venture capital backing; higher employee counts; a 58 percent boost in fundraising. Yet growth was not universal. Despite gains in top-line figures, the number of Kansas City-based…

        RX Savings Solutions sale would see the startup acquired for up to $875M in KC’s biggest-ever exit

        By Tommy Felts | September 19, 2022

        The McKesson Corporation has agreed to purchase Overland Park-prescribed Rx Savings Solutions in a deal worth nearly $1 billion.  McKesson announced Monday that it had entered into an agreement with the prescription pricing startup valued at up to $875 million — more than double the $425 million price tag for which Kansas City-built Backlot Cars…